Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-24-030971
Filing Date
2024-08-09
Accepted
2024-08-09 16:05:54
Documents
82
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 1871663
2 ex31-1.htm EX-31.1 17972
3 ex31-2.htm EX-31.2 18454
4 ex32-1.htm EX-32.1 7580
5 ex32-2.htm EX-32.2 7583
6 form10-q_001.jpg GRAPHIC 6238
  Complete submission text file 0001493152-24-030971.txt   9624780

Data Files

Seq Description Document Type Size
7 XBRL SCHEMA FILE meds-20240630.xsd EX-101.SCH 65543
8 XBRL CALCULATION FILE meds-20240630_cal.xml EX-101.CAL 79735
9 XBRL DEFINITION FILE meds-20240630_def.xml EX-101.DEF 309650
10 XBRL LABEL FILE meds-20240630_lab.xml EX-101.LAB 510290
11 XBRL PRESENTATION FILE meds-20240630_pre.xml EX-101.PRE 408560
84 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 1894609
Mailing Address 2420 BRUNELLO TRACE LUTZ FL 33558
Business Address 2420 BRUNELLO TRACE LUTZ FL 33558 (800) 261 0281
TRxADE HEALTH, INC (Filer) CIK: 0001382574 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39199 | Film No.: 241192589
SIC: 5122 Wholesale-Drugs, Proprietaries & Druggists' Sundries
(CF Office: 07 Trade & Services)